CD39 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD39 monoclonal antibodies for advanced research in immunology and cell biology. CD39 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD39, also known as ecto-nucleotide triphosphate diphosphohydrolase-1, plays a critical role in regulating immune responses by hydrolyzing ATP and ADP, thereby modulating purinergic signaling. CD39 maintains immune homeostasis and has been implicated in various pathological conditions, including cancer and autoimmune diseases. Understanding CD39 function is crucial for developing therapeutic strategies targeting immune modulation. Researchers worldwide rely on CD39 monoclonal antibodies to advance their investigations into immune system regulation. CD39 monoclonal antibodies enable precise detection and analysis of protein expression patterns across diverse experimental conditions. The high-quality CD39 monoclonal antibodies from Santa Cruz Biotechnology continue to support breakthrough discoveries in immunology research and therapeutic development.